Published in the Journal of Advanced Therapeutic Science, the framework proposes that amyloid and tau proteins are not the root cause of dementia but are instead components of an ancient protective response. This model explains a long-standing clinical mystery: why some individuals accumulate significant protein deposits while maintaining full cognitive health. Under this view, these proteins initially serve to combat infections or metabolic stress before the system becomes overwhelmed.
A New Theory Shifts the Focus of Alzheimer’s Research
Instead of viewing Alzheimer's as a primary disease of abnormal proteins, neuroscientist Dale E. Bredesen argues that neurodegeneration stems from the brain’s defensive reaction to chronic external threats. His new Pr2 theory suggests that pathology is merely a symptom of a neural system pushed toward sustained, damaging inflammation.
Bredesen posits that different neurodegenerative conditions, such as Parkinson’s or ALS, reflect vulnerabilities in specific neural networks. This shift in perspective moves the focus away from targeting individual proteins and toward a precision-medicine approach. By identifying and reversing the specific metabolic, environmental, or infectious drivers triggering a patient’s protective state, clinicians may be able to restore healthy neural function. While initial proof-of-concept studies show promise in reversing cognitive decline, the author calls for rigorous clinical testing to validate the scalability of these interventions.
Comments (0)
No comments yet. Be the first!